China Research and Intelligence (CRI) has emerged to provide high-level research and advisory services to all those with keen interest in different Chinese markets and industries. The firm, founded in 2007, is headquartered in Shanghai, China. Their team’s principle goal is to present the most helpful and reliable insights and information, sincerely serving a broad choice of multinational and local customers with their business practice and ethics.
CRI’s reports are packed with precise analysis of key market indicators, strategic recommendations from industry experts, market estimated figures, projections, reviews of competitive strategies, consumers investigation, reviews of business models, market share analyses, key forces driving of restraining market growth.
CRI’s scope of offerings encircles numerous market research reports, industry analytical reviews, company business reports, industry-specific research databases. Further, the company also offers outsource and custom-tailored services for research organisations, and multiple report readers.
Publications found:
1,334
Sort by:
Market Research Report on Polyresistin in China, 2010-2019
US$ 2,000.00
... the market size of Polyresistin. Through this report, readers can learn the followings and more: the market size of Polyresistin in China the market competition pattern of Polyresistin in China the sales price of Polyresistin produced by different enterprises in China the outlook on Polyresistin market in China The author recommends ...
February 2016
20 pages
Investigation Report on China Propofol Market, 2010-2019
US$ 2,000.00
... propofol products available in the Chinese market mainly come from AstraZeneca (Italy), Fresenius Kabi, Libang Pharmaceutical Group, Sichuan Shule Pharmaceutical Co., Ltd and B. Braun (Germany), among which AstraZeneca ...
September 2015
40 pages
Investigation Report on China Cefuroxime Market, 2010-2019
US$ 2,000.00
... ESSETI (Italy), GlaxoSmithKline (Italy), Medochemie Ltd. (Cyprus), SCCPC and GlaxoSmithKline plc. occupy the market, among which ESSETI ... cefuroxime in China competitive landscape of cefuroxime market in China price of cefuroxime made by different enterprises in China market outlook of cefuroxime in China ...
September 2015
40 pages
Investigation Report on China Cinepazide Market, 2010-2019
US$ 2,000.00
... cinepazide market in China is dominated by Beijing Hwellso Pharmaceutical Co., Ltd. Readers can get at least the following information through this report: market size of cinepazide in China competitive landscape of cinepazide market in China price of cinepazide ...
September 2015
20 pages
Investigation Report on China Ornidazole Market, 2010-2019
US$ 2,000.00
... Sichuan Kelun Pharmaceutical Co., Ltd, Xi’an Wanlong Pharmaceutical Co., Ltd, Shaanxi Jinyu Pharmaceutical Co., Ltd and Nanjing Sanhome Pharmaceutical Co., Ltd occupy the market, among which Sichuan Kelun Pharmaceutical Co., Ltd ...
September 2015
35 pages
Investigation Report on China Dydrogesterone Market, 2010-2019
US$ 2,000.00
... and tumor. As a new generation of progesterone, dydrogesterone of Abbott Biologicals B.V. (Netherland) has been marketed in ... dydrogesterone in China competitive landscape of dydrogesterone market in China price of dydrogesterone made by different enterprises in China market outlook of dydrogesterone in China ...
September 2015
20 pages
Investigation Report on China Alteplase Market, 2010-2019
US$ 2,000.00
... alteplase developed by Genentech is the mainstream product in global market. In China, only Actilyse, a life-saving injection of Boehringer-Ingelheim ... Boehringer-Ingelheim AG (Germany) and Shandong Ahua Biopharmaceutical Co., Ltd ...
September 2015
20 pages
Investigation Report on China Deproteinized Calf Blood Extract Market, 2010-2019
US$ 2,000.00
... Pharmaceutical Co., Ltd, Heilongjiang Jiangshi Pharmaceutical Co., Ltd, Harbin Sanctity Pharmaceutical Co., Ltd, Jilin Connell Pharmaceutical Co., Ltd and Wuhan Humanwell Pharmaceutical Co., Ltd occupy the market, among which Jinzhou Ahon Pharmaceutical Co., Ltd ...
September 2015
40 pages
Investigation Report on China Ioversol Market, 2010-2019
US$ 2,000.00
... non-ionic contrast medium, ioversol featuring low toxicity and few effects is mainly used to enhance the contrast of blood vessels in medical imaging. Containing iodine, ioversol ...
September 2015
30 pages
Research Report on China Foot-and-Mouth Disease (FMD) Vaccine Industry, 2010-2019
US$ 2,000.00
... China policy environment and government purchase of FMD vaccine in China supply of and demand for FMD vaccine in China major producers of FMD vaccine and their operation status in China factors affecting development of FMD vaccine in China expectation to FMD vaccine industry in China ...
August 2015
40 pages
Research Report on China Coke Industry 2010-2019
US$ 2,200.00
... Shanxi. And India, Japan and Mexico are the major export destinations. In 2014, 62.36 million tons of coking coal ... coke industry in China import and export of coke key enterprises of coke industry in China development trend of coke industry in China The author suggests the following groups ...
August 2015
70 pages
Investigation Report on China Anastrozole Market, 2010-2019
US$ 2,000.00
... anastrozole sales has went up slightly to CNY 184 million in 2014 with CAGR during the period of 2010-2014 reaching 4.89%. And AstraZeneca (US), Yangtze River Pharmaceutical Group, Huapont Pharm, Wanma Group and Hisun ...
August 2015
30 pages
Investigation Report on China Atracurium Market, 2010-2019
US$ 2,000.00
... Zhejiang Xianju Pharmaceutical Co., Ltd occupy the Chinese market, among which Jiangsu Hengrui reports an increasing share while Dong Ying (Jiangsu) Pharmaceutical and GlaxoSmithKline (Italy) report otherwise. And the price of atracurium ...
August 2015
30 pages
Investigation Report on China Cilostazol Market, 2010-2019
US$ 2,000.00
... Cilostazol enjoys a vast demand in China. Otsuka Co., Ltd, Zhejiang Weikang Pharmaceutical Co., Ltd, Chengdu Leer Pharmaceutical Co., Ltd, Pharsin and Yantai Yisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Otsuka Co., Ltd ...
August 2015
30 pages
Investigation Report on China Idarubicin Market, 2010-2019
US$ 2,000.00
... Pfizer Hisun Pharmaceutical Co., Ltd, Pharmacia&Upjohn (IT), Pharmacia&Upjohn (Suzhou) Pharmaceutical Co., Ltd, Pfizer Inc. (IT) and Nerviano Medical Science S.r.l. (IT) occupy the market, among which Pfizer Hisun Pharmaceutical Co., Ltd ...
August 2015
30 pages
Investigation Report on China Letrozole Market, 2010-2019
US$ 2,000.00
... breast cancer and as the second-line drug for breast cancer. At home, Jiangsu Hengrui Medicine Co., Ltd was approved to market letrozole under the trade name of Furui in 1999, followed by Femara ...
August 2015
20 pages
Investigation Report on China Leuprorelin Market, 2010-2019
US$ 2,000.00
... Leuprorelin enjoys a vast demand in China. And Livzon, Beijing Biote Pharmaceutical Co., Ltd and Takeda Pharmaceutical Co., Ltd (Japan) occupy the market, among which Takeda Pharmaceutical Co., Ltd ...
August 2015
30 pages
Investigation Report on China Lumbrokinase Market, 2010-2019
US$ 2,000.00
... Lumbrokinase is a fibrinolytic enzyme present in the earthworm Lumbricus bimastus ... lumbrokinase sales in Chinese sample hospitals has dropped from CNY 54 million in 2010 to CNY 43.39 million in 2014. And in 2014, Beijing Baiao Pharmaceuticals Co., Ltd ...
August 2015
30 pages
Investigation Report on China Nifedipine Market, 2010-2019
US$ 2,000.00
... nifedipin by Bayer researchers in 1966 opened a new chapter in the treatment of cardiovascular diseases. Developed by Bayer in 1992, nifedipin controlled release tablet (Adalat) has given a new life to nifedipin ...
August 2015
30 pages
Investigation Report on China Sevoflurane Market, 2010-2019
US$ 2,000.00
... MARUISHI PHARMACEUTICAL CO.,LTD.(JA), Shanghai Hengrui Pharmaceutical Co., Ltd, BAXTER HEALTHCARE CORPORATION(US), Jiangsu Hengrui Medicine Co., Ltd and MARUKO(JA) occupy the market, among which MARUISHI PHARMACEUTICAL CO.,LTD ...
August 2015
30 pages
Investigation Report on China Temozolomide Market, 2010-2019
US$ 2,000.00
... temozolomide products available in the Chinese market come from the following four companies: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd, Orion (Finland), Schering-Plough and Beijing SL Pharmaceutical Co., Ltd ...
August 2015
30 pages
Investigation Report on China Urokinase Market 2010-2019
US$ 2,000.00
... urokinase is widely used in treating such thrombotic diseases as acute myocardial infarction, cerebral thrombosis, pulmonary vein thrombus and deep vein thrombosis. With aging population and unreasonable eating habit, the incidence of thrombotic disease ...
August 2015
30 pages
Research Report on China Auto Parts Industry, 2010-2019
US$ 2,400.00
... auto parts competition in auto parts market in China import and export of auto parts in China major auto parts manufacturers in China expectation to auto parts industry in China The author suggests the following groups of people purchase this report: auto makers auto parts manufacturers ...
August 2015
60 pages
Research Report on China Wheat Industry, 2015-2019
US$ 2,200.00
... grain varieties in the world, wheat reported a yield of 126.21 million tons in 2014 in China, increasing 3.5% year on year. Wheat can not only make flour or fodder ... average consumption of flour as ration. Therefore, industrial use has become the major booster of wheat consumption. As wheat can also be used in ...
July 2015
50 pages
Investigation Report on China Quetiapine Market, 2010-2019
US$ 2,000.00
... disorder keeps going up, which fosters the vast demand for quetiapine in China. Currenly, Hunan Dongting Pharmaceutical Co., Ltd, Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory and AstraZeneca plc. occupy the majority of market share, among which AstraZeneca plc ...
July 2015
30 pages
Investigation Report on China Bevacizumab Market ,2010-2019
US$ 2,000.00
... China is higher than that in developed countries, it has decreased slightly in recent years. Developed by Roche under the trade name of Avastin, bevacizumab injection is the first angiogenesis inhibitor ...
July 2015
20 pages
Investigation Report on China Latanoprost Market, 2010-2019
US$ 2,000.00
... glaucoma provides a large market for conservative and postoperative medication. Therefore, latanoprost enjoys a vast demand in China. Pfizer Manufacturing Belgium NV, Pharmacia & Upjohn (Belgium), Lunan Better Pharmaceutical Co., Ltd, China Resources Zizhu Pharmaceutical Co., Ltd and Pharmacia & Upjohn ...
July 2015
30 pages
Investigation Report on China Pranoprofen Market, 2010-2019
US$ 2,000.00
... pranoprofen in China. Currently, pranoprofen in the Chinese market mainly come from the following three enterprises: Senju Pharmaceutical Co., Ltd, Shandong Haishan Pharmaceutical Co., Ltd and Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd, among which Senju Pharmaceutical Co.,Ltd ...
July 2015
20 pages
Investigation Report on China Ranibizumab Market, 2012-2019
US$ 2,000.00
... ranibizumab made by different enterprises in China market outlook of ranibizumab in China The author suggests the following groups of people purchase this report: manufacturers of monoclonal antibody ...
July 2015
20 pages
Investigation Report on China Tobramycin Market, 2010-2019
US$ 2,000.00
... infection. Currently, dozens of enterprises in China are able to produce tobramycin, among which the TOP5 are s.a. Alcon-Couvreur n.v., Sine Pharma, Kangya of Ningxia Pharmaceuticals Co., Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd and Shanghai Harvest Pharmaceutical Co., Ltd ...
July 2015
30 pages
Research Report on China Automobile Distribution Industry, 2010-2019
US$ 2,600.00
... automobile distribution industry in China key car dealers in China development trend of automobile distribution industry in China The author suggests the following groups of people purchase this report: car makers enterprises engaged in auto trade ...
July 2015
50 pages
Research Report on China Boiler Industry, 2010-2019
US$ 2,200.00
... boiler industry reason why gas-fired boiler replaced coal-burning boiler competition in boiler industry in China major boiler manufacturers in China expectation to boiler industry in China The author suggests the following groups ...
July 2015
50 pages
Research Report on China Machine Tool Industry, 2010-2019
US$ 2,400.00
... investment. For instance, the consumption of metal-cutting machine tool has decreased while that of metal-forming machine tool keeps growing. Besides, the import and domestic output of vertical machining center ...
July 2015
60 pages
Investigation Report on China Glipizide Market, 2010-2019
US$ 2,000.00
... China while other companies like Shandong Wanjie High-tech Co., Ltd, Yangtze River Pharmaceutical Group and Disha Pharmaceutical Group shared the rest market share. The annual sales value of glipizide ...
July 2015
30 pages
Investigation Report on China Gliquidone Market, 2010-2019
US$ 2,000.00
... Beijing Wanhui Double-Crane Pharmaceutical Co., Ltd took up a market share of about 97% for sales value in China while other companies like TIPR Pharmaceutical Responsible Co., Ltd, Jiangsu Vanguard Pharmaceutical Co., Ltd and Jilin Jinheng Pharmaceutical Co., Ltd and Shijiazhuang Yiling Pharmaceutical ...
July 2015
30 pages
Investigation Report on China Sorafenib Market, 2010-2019
US$ 2,000.00
... cancer and kidney cancer in China grows gradually. According to the Guidelines for Kidney Cancer Diagnosis and Treatment in China (the 2013 version), kidney cancer accounts for 2%-3% of adult malignant tumors in China ...
July 2015
20 pages
Research Report on China Photovoltaic (PV) Industry, 2015-2019
US$ 2,800.00
... China became the largest photovoltaic producer with export reaching USD 2.838 billion. In 2014, China’s total imports and exports of solar photovoltaic cell ... photovoltaic generation has developed fast in China. In 2014, the installed capacity of photovoltaic grid-connected generation in China ...
July 2015
60 pages
Investigation Report on China Parecoxib Market, 2010-2019
US$ 2,000.00
... analgesia. Parecoxib, the first COX-2 inhibitor which can be injected through vein and muscle, was developed by Pharmacia & Upjohn and approved to ... trade name of Dynastat in early 2002. Currently, it has been marketed in over 10 countries in the world. Parecoxib develops fast after entering China in 2008. ...
July 2015
25 pages
Investigation Report on China Ambroxol Market, 2010-2019
US$ 2,000.00
... Boehringer Ingelheim (Spain), Shenya Xin Ma Pharmaceutical Co., Ltd, Changzhou Siyao Pharmaceuticals Co., Ltd and Boehringer Ingelheim (Shanghai) occupy the majority of the Chinese market, among which Boehringer Ingelheim ...
July 2015
40 pages
